Phase I Photodynamic Therapy (PDT) for Benign Dermal Neurofibromas (NF1)

NCT01682811 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Neurofibromatoses

Interventions

DRUG: Part 1 Levulan injection
DRUG: Part 1 Levulan surface application
DRUG: Part 1 Levulan surface application twice
DRUG: Part 1 Levulan surface application twice with microneedling
DRUG: Levulan (5-aminolevulinic acid) photodynamic therapy - Dose level 1
DRUG: Levulan (5-aminolevulinic acid) photodynamic therapy - Dose level 2
DRUG: Levulan (5-aminolevulinic acid) photodynamic therapy - Dose level 3

Sponsor

Harry T Whelan, MD